Company intelligence / Profile preview

Azurite Management

Ohio, United States

Ownership: Private
Development stage: Other

Overview

Azurite Management is a private investment firm and SEC-referenced investment adviser focused primarily on investing in publicly traded undervalued and underperforming U.S. companies. The firm appears to operate as an investment manager and activist shareholder rather than as a biotechnology, pharmaceutical, or healthcare operating company. Public references tie Azurite Management to shareholder activism at Invacare, where it was described as the company’s largest shareholder in 2022. Based on the available evidence, Azurite Management does not develop therapeutic products, run a drug pipeline, or provide life science R&D services.

Industry: Investors

Partnerships

Invacare (cooperation agreement as major shareholder/activist investor)

Beyond the preview

Go deeper on Azurite Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Azurite Management.

Explore the full profile